Press Releases 

Uptick Network’s “Stock Day” News Program Interviews New Proposed Joint Venture Partner of Skyline M

Eagan, MN (Uptick Newswire – November 13, 2017) – Uptick Network today announced that it has interviewed Gerald Vardzel. CEO of Helomics Corp., the planned joint venture partner of Skyline Medical (SKLN). Starting off the interview Mr. Vardzel discusses the company’s new key reconstruction and the 3 strategic pillars that are making Helomics profitable in discovery and development. Continuing the interview, he touches on the overall value and variation of Helomics CRO Services for clinical research organizations. Furthermore, Mr. Vardzel elaborates on the impact and differentiation that Helomics has for the future of testing live tumors from patients and briefly discusses the potential joint

Skyline Medical Inc. Enters into Strategic Collaboration with Helomics to Develop Next Generation of

MINNEAPOLIS (November 1, 2017) - Skyline Medical Inc. (NASDAQ: SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, and Helomics Corporation (Pittsburgh, PA) have announced a strategic collaboration to use the Helomics D-CHIP™ platform to develop new approaches for personalized cancer diagnosis and care. Helomics has amassed large quantities of data on patients with cancer as part of its ChemoFx® precision cancer diagnostic. This rich “big-data” repository contains the drug response profiles of over 149,000 patient tumors and their molecular, genomic, biochemical and histopathology data coupled to de-identi

Archive
 Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • Twitter Basic Square

© 2020 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon